EHEC Diagnosis and Management
If your patient has bloody diarrhea, immediately order stool testing for STEC using both culture (for O157) and Shiga toxin detection (for non-O157 strains), provide aggressive IV hydration, and avoid antibiotics. 1
Clinical Presentation
EHEC (Shiga toxin-producing E. coli) causes acute bloody diarrhea with severe abdominal cramping. The critical concern is progression to hemolytic uremic syndrome (HUS)—occurring in approximately 8% of O157 infections—characterized by thrombocytopenia, hemolytic anemia, and renal failure 2. Children under 5 years have the highest risk for both infection and HUS development 2.
Key epidemiologic clues:
- Consumption of undercooked ground beef, unpasteurized dairy, raw produce (lettuce, sprouts), or contaminated water
- Contact with animals or farm environments
- Person-to-person transmission in childcare settings
- Low infectious dose (<100 organisms for O157 and O111) 2
Diagnostic Approach
Stool testing is mandatory when patients present with:
- Bloody or mucoid stools
- Fever with diarrhea
- Severe abdominal cramping or tenderness
- Signs of sepsis 1
Laboratory Testing Algorithm
Dual testing approach (most effective): 2
- Culture on sorbitol-MacConkey agar (or chromogenic alternative) for O157:H7
- Shiga toxin detection by EIA or PCR for both O157 and non-O157 strains
- This combination is superior to either method alone
Additional workup:
- Complete blood count with differential (watch for leukocytosis, thrombocytopenia)
- Basic metabolic panel (monitor creatinine)
- Daily platelet counts during days 1-14 if STEC confirmed—declining platelets signal HUS risk 1
Blood cultures indicated if: 1
- Age <3 months
- Signs of septicemia
- Immunocompromised status
- Sustained fever despite treatment
Critical pitfall: Many laboratories don't routinely test for STEC—you must specifically request it 2.
Management
Supportive Care (Primary Treatment)
Aggressive parenteral volume expansion is the cornerstone of therapy and may reduce renal damage when initiated early 2. This is particularly crucial given the 8% HUS risk.
- Assess and correct dehydration status immediately (especially in young children and elderly) 1
- IV fluid resuscitation for moderate-severe cases
- Monitor urine output, blood pressure, and volume status
- Daily monitoring of platelets and creatinine until stable/improving 1
What NOT to Do
Avoid antibiotics—they are associated with more severe disease and may increase HUS risk by triggering Shiga toxin release 2. This is a critical distinction from other bacterial causes of bloody diarrhea (Salmonella, Shigella, Campylobacter) where antibiotics may be beneficial 1.
Avoid antimotility agents and narcotics—these do not shorten illness and may worsen outcomes 3.
Monitoring for HUS
Watch for:
- Declining platelet count (trend more important than single value)
- Rising creatinine
- Hemolytic anemia (schistocytes on smear)
- Oliguria or anuria
- Hypertension with volume overload 1
If HUS develops: Transfer to center capable of managing acute renal failure; may require hemodialysis and plasmapheresis 4.
Public Health Considerations
- Report confirmed cases to local health authorities immediately
- Follow-up stool cultures may be required before return to childcare, food handling, or healthcare work 1
- Outbreak investigation may be warranted—coordinate with public health 1
Serotype Considerations
While O157:H7 remains most common in North America, non-O157 serotypes (particularly O26, O103, O111, O145) are increasingly recognized 5, 6. Strains producing only Stx2 carry higher HUS risk than those producing Stx1 alone 2. This underscores why Shiga toxin detection (not just O157 culture) is essential.